News
🌏 NMPA Page 3Latest pharmaceutical news, drug approvals, and NMPA regulatory updates
Showing 25–36 of 248 articles
Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's
FDA · Alzheimer's disease · 4 min
Sophie MartinOptical Coherence Tomography Pharma Filings
FDA · 6 min
Sophie MartinDatroway Approved: A New Hope for Metastatic TNBC Patients
FDA · metastatic TNBC · 5 min
Sophie MartinBig Pharma's China Oncology Trials: Navigating a Landscape of Reduced Scrutiny
FDA · oncology · 5 min
Sophie MartinPREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI
FDA · 5 min
Sophie MartinKissei Pharmaceutical Halts Tavneos Use Amid Deaths
FDA · 6 min
Sophie MartinPMDA Approves New Pharmaceuticals and Medical Devices: What's New
PMDA · 4 min
Sophie MartinGlobal Regulatory Agencies Update Real-World Evidence Guidance for Decision-Making
7 min
Sophie MartinChina's Ascendancy in Oncology Research Alarms European Oncologists, Threatening Europe's Competitive Edge
oncology · 9 min
Sophie MartinASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements
oncology · 6 min
Sophie MartinHong Kong Overhauls Drug Approval Process: What Pharma BD Teams Need to Know
FDA · 8 min
Sophie MartinBeOne Medicines' HERIZON-GEA Phase 3 Data in NEJM: A Deep Dive for Pharma BD and Investors
FDA · 6 min
Sophie MartinPopular topics
- Drug Approvals 1,138 articles
- Clinical Trials 652 articles
- Regulatory Updates 695 articles
- Press Releases 443 articles
- Oncology 456 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 143 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways